Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous corifollitropin alfa stimulation in DUOSTIM cycles
2022-003177-32Phase 4Active
- Sponsor
- Instituto Bernabeu
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of corifollitropin alfa in poor ovarian response (POR), sponsored by Instituto Bernabeu. Primary endpoint: Total number of oocytes obtained. Started Oct 2022; status: active.
02
Drugs
corifollitropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on 2022-003177-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003177-32.